Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Actualités Accéder au fil d'actualités

Tempus AI secures $1.1 billion in data contracts, shares rally

Tempus AI said it signed $1.1 billion in sealed data contracts with 70 customers in 2025, including major life-sciences firms such as AstraZeneca, Pfizer, Merck and Abbvie. The company reported revenue retention around 126% and called 2025 a record year for its Data and Applications business. Shares rose as much as 15% intraday and closed up 4.51% at $69.26. Tempus AI plans to finalize and report full 2025 financial results on an earnings call in February 2026. » Plus sur finance.yahoo.com
Tempus AI raises FY25 guidance, cites FDA clearance and Paige acquisition as growth drivers

Tempus AI guided FY25 revenue to $1.25–$1.26 billion (about 81% YoY) and expects roughly $1.55 billion in FY26 revenue, valuing the company at ~9.16x 2026 sales. Recent catalysts include FDA clearance for its xR IVD product and the $81 million acquisition of Paige, which expand addressable markets and AI pathology capabilities. Analysts note strong revenue visibility and execution, while valuation appears supported by forward growth despite a trailing P/E around 41.5 and elevated share performance since April. » Plus sur finance.yahoo.com
Tempus AI reaches all-time high of $98.14

Tempus AI stock climbed to an all-time high of $98.14, bringing market capitalization to about $16.16 billion. Analyst price targets range from $60 to $100; Guggenheim raised its target to $95 and H.C. Wainwright to $98. Tempus recorded revenue growth of 59.84% over the last twelve months and a 1-year performance of +96.54%. The company received FDA 510(k) clearance for the RNA-based diagnostic Tempus xR IVD and expanded its CARE program for breast cancer screening. » Plus sur de.investing.com

Dividendes historiques Dividendes

Tous les indicateurs de dividendes Tous les indicateurs

En 2023, TEMPUS CAPITAL INC. a déjà versé 0,034 € de dividendes. Le dernier versement a eu lieu en août 2023.

Données financières de l'entreprise

Au dernier trimestre, TEMPUS CAPITAL INC. a réalisé un chiffre d'affaires de 73,2 k € et un bénéfice net de -34,56 k €

(EUR)	juin 2026	YoY
Chiffre d'affaires	73,2 k	2,72 %
Bénéfice brut	36,96 k	2,92 %
Bénéfice net	-34,56 k	11,85 %
EBITDA	2,21 k	243,99 %

Données fondamentales

Indicateur	Valeur
Capitalisation boursière	950,18 k €
Nombre d'actions	30,48 M
Plus haut/bas sur 52 semaines	0,053 € - 0,0249 €
Dividendes	Non
Bêta	-0,04
Ratio P/E	-5,95
Ratio PEG	2,99
Ratio P/B	0,90
Ratio P/S	3,09

Profil de l'entreprise

Tempus Capital Inc. ist als Immobilienunternehmen in Kanada tätig. Das Immobilienportfolio des Unternehmens umfasst vier Immobilien, darunter eine Gewerbefläche, eine Gewerbeimmobilie und zwei gemischte Gewerbe-/Wohnimmobilien in Ontario. Tempus Capital Inc. wurde im Jahr 2011 gegründet und hat seinen Sitz in Burlington, Kanada.